Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial.

Clicks: 489
ID: 48923
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 8 articles by views in pharmacopsychiatry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Saffron (.) has demonstrated antidepressant effects in clinical studies and extensive anxiolytic effects in experimental animal models. 66 patients with major depressive disorder accompanied by anxious distress were randomly assigned to receive either saffron (30 mg/day) or citalopram (40 mg/day) for 6 weeks. Hamilton Rating Scale for Depression (HAM-D) and Hamilton Rating Scale for Anxiety (HAM-A) were used to assess treatment effect during the trial. 60 participants finished the study. Patients who received either saffron or citalopram showed significant improvement in scores of the Hamilton Rating Scale for Depression (P-value<0.001 in both groups) and Hamilton Rating Scale for Anxiety (P-value<0.001 in both groups). Comparison of score changes between the 2 trial arms showed no significant difference (P-value=0.984). Frequency of side effects was not significantly different between the 2 groups. The present study indicates saffron as a potential efficacious and tolerable treatment for major depressive disorder with anxious distress.
Reference Key
ghajar2017crocuspharmacopsychiatry Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ghajar, A;Neishabouri, S M;Velayati, N;Jahangard, L;Matinnia, N;Haghighi, M;Ghaleiha, A;Afarideh, M;Salimi, S;Meysamie, A;Akhondzadeh, S;
Journal pharmacopsychiatry
Year 2017
DOI
10.1055/s-0042-116159
URL
Keywords
depression saffron curcumin clinical trial antidepressant turmeric

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.